| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 12.380 | 99.505 | 74.883 | 66.181 |
| Total Income - EUR | - | - | - | - | - | - | 13.164 | 99.516 | 74.973 | 70.563 |
| Total Expenses - EUR | - | - | - | - | - | - | 14.968 | 73.275 | 72.945 | 47.825 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.804 | 26.240 | 2.028 | 22.737 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -2.198 | 23.315 | 1.720 | 19.384 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Winkelmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 32 | 0 | 0 | 57 |
| Current Assets | - | - | - | - | - | - | 8.013 | 52.543 | 62.849 | 81.935 |
| Inventories | - | - | - | - | - | - | 2.735 | 29.931 | 35.858 | 46.985 |
| Receivables | - | - | - | - | - | - | 15.250 | 13.283 | 14.582 | 17.516 |
| Cash | - | - | - | - | - | - | -9.971 | 9.329 | 12.408 | 17.434 |
| Shareholders Funds | - | - | - | - | - | - | -2.158 | 21.150 | 22.806 | 42.062 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 10.203 | 31.393 | 40.043 | 39.930 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Winkelmed S.r.l.